The regenerative medicine market is an exciting and rapidly evolving sector within the healthcare industry. This market focuses on the development and application of therapies and technologies ...

Stratham STEAM teacher brings regenerative medicine to life through interactive classroom projects, earns award from NH Tech Alliance Provided by UNH Tech Camp/Tech for Teachers Institute May 27, 2025 ...

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions. However, while scientific breakthroughs in regenerative medicines ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

Medical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics that expands its business into regenerative medicine. Osiris makes medical products ...

In principle, transplantation of mesenchymal progenitor cells would attenuate or possibly correct genetic disorders of bone, cartilage and muscle, but clinical support for this concept is lacking.

The criteria for consideration of translational and clinical research in Nature Medicine are originality, timeliness and impact on improving human health by addressing unmet clinical needs.

Join us on June 30th at Tivoli Vredenburg, Utrecht to celebrate 10 years of Regenerative Medicine Utrecht (RMU), a celebration of progress, innovation, and teamwork in regenerative medicine, shaping ...

Equus How did horses become some of the greatest athletes in the animal kingdom? Researchers at Johns Hopkins Medicine have pinpointed a genetic mutation and evolutionary process that occurred ...

Space is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.

Live Regenerative Medicine news coverage of developments with the latest updates. Stay on top of latest Regenerative Medicine news stories and find out what just happened, what is going on with ...

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are ...